Sign up to save your podcasts
Or
Share Phil Southerland - Pro Cycling | Continuous Glucose Monitoring | Abbott Partnership
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Phil Southerland - Pro Cycling | Continuous Glucose Monitoring | Abbott Partnership
Phil Southerland is the CEO and Co-Founder of Supersapiens.
In 2019, Supersapiens approached Abbott about bringing their technology to the athletic community, and a partnership was soon established.
In September 2020, Abbott announced that its Libre Sense Glucose Sport Biosensor had achieved a CE Mark. It is the first CGM approved for non-diabetic use in the world.
By combining Abbott's proven track record in glucose sensing technology along with Supersapiens' app and personalized analytics, athletes are able to better understand the correlation between their glucose levels and their athletic performance.
View all episodes
By Jonathan PfaffenrotPhil Southerland is the CEO and Co-Founder of Supersapiens.
In 2019, Supersapiens approached Abbott about bringing their technology to the athletic community, and a partnership was soon established.
In September 2020, Abbott announced that its Libre Sense Glucose Sport Biosensor had achieved a CE Mark. It is the first CGM approved for non-diabetic use in the world.
By combining Abbott's proven track record in glucose sensing technology along with Supersapiens' app and personalized analytics, athletes are able to better understand the correlation between their glucose levels and their athletic performance.